Thyroid Cancer News and Research RSS Feed - Thyroid Cancer News and Research

Thyroid Cancer is cancer that forms in the thyroid gland (an organ at the base of the throat that makes hormones that help control heart rate, blood pressure, body temperature, and weight). Four main types of thyroid cancer are papillary, follicular, medullary, and anaplastic thyroid cancer. The four types are based on how the cancer cells look under a microscope.
International panel reclassifies a type of thyroid tumor to reduce cancer overdiagnosis

International panel reclassifies a type of thyroid tumor to reduce cancer overdiagnosis

Led by researchers at the University of Pittsburgh School of Medicine, an international panel of pathologists and clinicians has reclassified a type of thyroid cancer to reflect that it is noninvasive and has a low risk of recurrence. The name change, described today in JAMA Oncology, is expected to reduce the psychological and medical consequences of a cancer diagnosis, potentially affecting thousands of people worldwide. [More]
New ultra-sensitive technique shows promise as diagnostic tool for cancers, HIV

New ultra-sensitive technique shows promise as diagnostic tool for cancers, HIV

A common theme in medicine is that detecting a disease early on can lead to more effective treatments. This relies partly on luck that the patient gets screened at the right time, but more important is that the testing techniques are sensitive enough to register the minuscule hints that diseases leave in the blood stream. [More]
Simple method could make early disease diagnosis much easier

Simple method could make early disease diagnosis much easier

Detecting diseases such as cancer in their earliest stages can make a huge difference in patient treatment, but it is often difficult to do. Now scientists report in the journal ACS Central Science a new, simple method that could make early disease diagnosis much easier. [More]
New report reveals malignant brain tumors as most common cause of cancer-related deaths in young people

New report reveals malignant brain tumors as most common cause of cancer-related deaths in young people

A new report published in the journal Neuro-Oncology and funded by the American Brain Tumor Association finds that malignant brain tumors are the most common cause of cancer-related deaths in adolescents and young adults aged 15-39 and the most common cancer occurring among 15-19 year olds. [More]
Abingworth announces closing of $105m clinical co-development fund

Abingworth announces closing of $105m clinical co-development fund

Abingworth, the international investment group dedicated to life sciences, today announced the closing of the $105m Abingworth Clinical Co-Development Fund (ACCF), its 11th life sciences fund. ACCF was oversubscribed, exceeding its target of $100 million, and will co-invest with other Abingworth funds. [More]
Combining nanomedicine with two anticancer treatments could improve outcomes for pancreatic cancer patients

Combining nanomedicine with two anticancer treatments could improve outcomes for pancreatic cancer patients

A nanoparticle drug-delivery system that combines two complementary types of anticancer treatment could improve outcomes for patients with pancreatic cancer and other highly treatment-resistant tumors while decreasing toxicity. [More]
LabCorp to offer Interpace's new ThyraMir microRNA classifier test

LabCorp to offer Interpace's new ThyraMir microRNA classifier test

Interpace Diagnostics announced today that Laboratory Corporation of America Holdings, the world's leading health care diagnostics company, will begin offering Interpace's new ThyraMir microRNA classifier test. [More]
Cancer mortality continues to drop in the U.S.

Cancer mortality continues to drop in the U.S.

Steady reductions in smoking combined with advances in cancer prevention, early detection, and treatment have resulted in a 23% drop in the cancer death rate since its peak in 1991. The drop translates to more than 1.7 million cancer deaths averted through 2012. [More]
Chi-Med announces initiation of Phase III sulfatinib registration trial in patients with NETs in China

Chi-Med announces initiation of Phase III sulfatinib registration trial in patients with NETs in China

Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited, its drug R&D subsidiary, has initiated SANET-ep, a Phase III sulfatinib (HMPL-012) registration trial in China in patients with extra-pancreatic neuroendocrine tumors ("NETs"), which are all non-pancreatic NETs, including, for example, NETs originating in the lymph, lung and across the gastrointestinal tract. [More]
New research sheds light on outcomes for patients with thyroid cancer

New research sheds light on outcomes for patients with thyroid cancer

Thyroid cancer survivors report poor quality of life after diagnosis and treatment compared with other patients who are diagnosed with more lethal cancers, according to new research from the University of Chicago Medicine. [More]
Advanced thyroid cancer rates above national average in several parts of California

Advanced thyroid cancer rates above national average in several parts of California

A team of UCLA researchers found that there are several parts of California where, in a high percentage of people with thyroid cancer, the disease is already at an advanced stage by the time it is diagnosed. [More]
Patients with kidney failure at increased risk of developing different types of cancer

Patients with kidney failure at increased risk of developing different types of cancer

For patients with kidney failure, poor kidney function and immunosuppressant medications may increase their risk of developing different types of cancer. The findings, which are published in a study appearing in an upcoming issue of the Journal of the American Society of Nephrology, suggest the need for persistent cancer screening and prevention in these patients. [More]
Study highlights possible inaccuracies in thyroid cancer detection tests

Study highlights possible inaccuracies in thyroid cancer detection tests

Protein biomarkers are used to test for cancer before and after surgeries to remove tumors. To test thyroid malignancy, many biomarkers are tested separately to confirm cancer. However, new research from Michigan Technological University shows that the detection tests that measure two major biomarkers to diagnose thyroid cancer may be inaccurate. [More]
Hutchison MediPharma begins sulfatinib Phase I trial in US

Hutchison MediPharma begins sulfatinib Phase I trial in US

Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, has initiated the Phase I clinical trial of sulfatinib (HMPL-012) in the United States. [More]
Research provides novel insight into potential new therapeutic targets for triple-negative breast cancer

Research provides novel insight into potential new therapeutic targets for triple-negative breast cancer

Recent laboratory findings provide novel insight into potential new therapeutic approaches for triple-negative breast cancer, a particularly difficult to treat and aggressive form of the disease. [More]
Nagoya University professor receives 2015 Van Meter Award for thyroid research

Nagoya University professor receives 2015 Van Meter Award for thyroid research

Takashi Yoshimura, a professor at the Institute of Transformative Bio-Molecules at Nagoya University in Japan, has won the 2015 Van Meter Award for his contributions to thyroid research. [More]
Latest research on thyroid cancer to be highlighted at 15th International Thyroid Congress

Latest research on thyroid cancer to be highlighted at 15th International Thyroid Congress

The effect of radiation exposure related to the nuclear accidents that took place in Fukushima, Japan, and Chernobyl, Ukraine on thyroid cancer risk, whether dietary habits influence the risk of developing thyroid cancer, and recent study results with a triiodothyronine (T3) analog in an uncommon form of thyroid disease are all topics featured in oral presentations delivered at the 15th International Thyroid Congress, hosted by the American Thyroid Association, October 18-23, 2015, in Orlando, Florida. [More]

New ATA guidelines for managing adult patients with thyroid nodules and DTC published in Thyroid journal

New, evidence-based recommendations from the American Thyroid Association will help guide clinicians in managing patients with thyroid nodules, a common disorder that requires evaluation to distinguish benign nodules from malignancy, interpret biopsy results and molecular marker studies, and initiate risk assessment and cancer screening. [More]
ATA announces research grants to support projects proposed by young researchers

ATA announces research grants to support projects proposed by young researchers

The American Thyroid Association is pleased to announce that grants have been awarded to support projects proposed by leading young researchers. Three of these projects involve the genetic analysis of thyroid tumors carrying the BRAFV600E mutation, which is associated with the development of some forms of thyroid cancer and increased risk for distant metastases, more advanced disease, and higher mortality. [More]
ATA announces first-year research grants to support promising young researchers

ATA announces first-year research grants to support promising young researchers

The American Thyroid Association (ATA) is pleased to announce the awarding of first-year grants to support two young researchers selected from among a pool of applicants who proposed projects that will contribute novel insights and information with the potential to lead to new drug targets and therapeutic strategies to improve the treatment of thyroid cancer and patient outcomes. [More]
Advertisement